Life Scientists, All Other
AI 替代率
60%这个岗位当前已结合 4 条时间线资讯和岗位画像推理来给出替代率。
AI, with models like GPT-Rosalind and virtual cell platforms, is significantly transforming life science research, accelerating drug discovery, genomics, and experimental design. These advancements are shifting R&D from traditional experiment-driven to AI-driven virtual simulations, enabling automated hypothesis generation and continuous data analysis, thus indicating a high potential for role augmentation and replacement across various scientific workflows.
替代率趋势
按周期刷新快照聚合- 2026-04-2065%
为什么是这个等级
结构底座OpenAI introduced GPT-Rosalind, a frontier reasoning model designed to accelerate complex life science workflows including drug discovery, genomics analysis, protein reasoning, hypothesis generation, and experimental planning. This directly automates and augments high-level scientific tasks previously requiring extensive human intellect and synthesis.
Baiyao Technology's AI virtual cell (AIVC) platforms enable life scientists to conduct large-scale virtual experiments, simulating cell behavior and predicting changes. This fundamentally shifts drug development from traditional 'experiment-driven' to 'model-driven' R&D, significantly enhancing efficiency and reducing the need for physical lab work in early stages.
GPT-Rosalind, along with its Codex plugin, acts as an 'orchestration layer' to synthesize evidence, generate hypotheses, and plan experiments across multiple scientific databases and literature. This streamlines traditionally fragmented research workflows, making manual steps more consistent and repeatable.
Companies like SHANMU are developing AI-native health hardware for continuous, multi-modal biological data collection from various sources. This technology enables AI Agents to provide proactive health management, automating aspects of data acquisition, monitoring, and early diagnostic research that inform life science studies.
时间线
按时间倒序展示相关资讯与案例AI虚拟细胞（AIVC）平台公司百曜科技完成新一轮融资，将用于迭代AI虚拟细胞算法模型、建设数据收集平台及加速产业化落地。该技术将AI建模层级从“分子”提升至“细胞”，使生命科学家能够在数字环境中进行大规模虚拟实验，将研发流程从“实验驱动”转变为“模型驱动”，有望显著降低研发成本、缩短开发周期，并提升药物研发的整体成功率，从而深刻影响生命科学领域的工作方式。
打开原文AI原生健康硬件公司「杉木SHANMU」完成近亿元A轮融资。该公司开发微型高精度全自动生化分析仪，可嵌入马桶等日常用品中，持续无感地获取尿液、唾液、汗液中的分子、细胞、蛋白等生物指标。通过构建“个人健康计算”的生命操作系统，AI Agent与真人医生团队将基于连续多模态生物数据，实现预测式、个性化健康干预，彻底重构传统健康监测和管理的工作流程。
打开原文OpenAI introduced GPT-Rosalind, a specialized AI model and an accompanying Codex plugin for life sciences research. This tool is designed to accelerate biological and chemical discovery by synthesizing evidence, generating hypotheses, and planning experiments, streamlining traditionally fragmented workflows for scientists in areas like genomics and protein engineering.
打开原文OpenAI launched GPT-Rosalind, a new frontier reasoning model aimed at accelerating drug discovery, genomics analysis, protein reasoning, and overall scientific research workflows for life scientists.
打开原文